Arthur Besse

Arthur Besse is a pseudonym chosen by a group of French differential geometers, led by Marcel Berger, following the model of Nicolas Bourbaki. A number of monographs have appeared under the name. Provided by Wikipedia
Showing 1 - 5 results of 5 for search 'A. Besse', query time: 0.04s Refine Results
  1. 1
    Arabika Coffee Production Capacity Planning with Rough Cut Capacity Planning (RCCP)

    Arabika Coffee Production Capacity Planning with Rough Cut Capacity Planning (RCCP) by Riyani Indah A. Besse, Pongrekun Kesia, Setiawan Irwan

    Published 2024-01-01
    Get full text
    Article
  2. 2
    Prevalence and variability of siderophore production in the Achromobacter genus

    Prevalence and variability of siderophore production in the Achromobacter genus by P. Sorlin, E. Brivet, V. Jean-Pierre, F. Aujoulat, A. Besse, C. Dupont, R. Chiron, E. Jumas-Bilak, Q. Menetrey, H. Marchandin

    Published 2024-03-01
    Get full text
    Article
  3. 3
    The minichromosome maintenance complex drives esophageal basal zone hyperplasia

    The minichromosome maintenance complex drives esophageal basal zone hyperplasia by Mark Rochman, Yrina Rochman, Julie M. Caldwell, Lydia E. Mack, John A. Besse, Nathan P. Manes, Sung Hwan Yoon, Tetsuo Shoda, Aleksandra Nita-Lazar, Marc E. Rothenberg

    Published 2023-09-01
    Get full text
    Article
  4. 4
    Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth.

    Targeted ablation of miR-21 decreases murine eosinophil progenitor cell growth. by Thomas X Lu, Eun-Jin Lim, Svetlana Itskovich, John A Besse, Andrew J Plassard, Melissa K Mingler, Joelle A Rothenberg, Patricia C Fulkerson, Bruce J Aronow, Marc E Rothenberg

    Published 2013-01-01
    Get full text
    Article
  5. 5
    P45 HIGH-DOSE CARFILZOMIB ACHIEVES SUPERIOR ANTI-TUMOR ACTIVITY OVER LOW-DOSE AND RECAPTURES RESPONSE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RESISTANT TO LOW-DOSE CARFILZOMIB BY CO-INHIBITING THE B2 AND B1 PROTEASOME SUBUNITS

    P45 HIGH-DOSE CARFILZOMIB ACHIEVES SUPERIOR ANTI-TUMOR ACTIVITY OVER LOW-DOSE AND RECAPTURES RESPONSE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA RESISTANT TO LOW-DOSE CARFILZOMIB BY C... by X. Zhou, A. Besse, J. Peter, M. J. Steinhardt, C. Vogt, S. Nerreter, E. Teufel, E. Stanojkovska, X. Xiao, H. Hornburger, L. Haertle, M. Mendez Lopez, U. Munawar, A. Riedel, S. Han, E. Maurits, H. S. Overkleeft, B. Florea, H. Einsele, K. M. Kortüm, C. Driessen, L. Besse, L. Rasche

    Published 2023-05-01
    Get full text
    Article

Search Tools: